Literature DB >> 23607566

Hypoxia alters ocular drug transporter expression and activity in rat and calf models: implications for drug delivery.

Rajendra S Kadam1, Preveen Ramamoorthy, Daniel J LaFlamme, Timothy A McKinsey, Uday B Kompella.   

Abstract

Chronic hypoxia, a key stimulus for neovascularization, has been implicated in the pathology of proliferative diabetic retinopathy, retinopathy of prematurity, and wet age related macular degeneration. The aim of the present study was to determine the effect of chronic hypoxia on drug transporter mRNA expression and activity in ocular barriers. Sprague-Dawley rats were exposed to hypobaric hypoxia (PB = 380 mmHg) for 6 weeks, and neonatal calves were maintained under hypobaric hypoxia (PB = 445 mmHg) for 2 weeks. Age matched controls for rats, and calves were maintained at ambient altitude and normoxia. The effect of hypoxia on transporter expression was analyzed by qRT-PCR analysis of transporter mRNA expression in hypoxic and control rat choroid-retina. The effect of hypoxia on the activity of PEPT, OCT, ATB(0+), and MCT transporters was evaluated using in vitro transport studies of model transporter substrates across calf cornea and sclera-choroid-RPE (SCRPE). Quantitative gene expression analysis of 84 transporters in rat choroid-retina showed that 29 transporter genes were up regulated or down regulated by ≥1.5-fold in hypoxia. Nine ATP binding cassette (ABC) families of efflux transporters including MRP3, MRP4, MRP5, MRP6, MRP7, Abca17, Abc2, Abc3, and RGD1562128 were up-regulated. For solute carrier family transporters, 11 transporters including SLC10a1, SLC16a3, SLC22a7, SLC22a8, SLC29a1, SLC29a2, SLC2a1, SLC3a2, SLC5a4, SLC7a11, and SLC7a4 were up regulated, while 4 transporters including SLC22a2, SLC22a9, SLC28a1, and SLC7a9 were down-regulated in hypoxia. Of the three aquaporin (Aqp) water channels, Aqp-9 was down-regulated, and Aqp-1 was up-regulated during hypoxia. Gene expression analysis showed down regulation of OCT-1, OCT-2, and ATB(0+) and up regulation of MCT-3 in hypoxic rat choroid-retina, without any effect on the expression of PEPT-1 and PEPT-2. Functional activity assays of PEPT, OCT, ATB(0+), and MCT transporters in calf ocular tissues showed that PEPT, OCT, and ATB(0+) functional activity was down-regulated, whereas MCT functional activity was up-regulated in hypoxic cornea and SCRPE. Gene expression analysis of these transporters in rat tissues was consistent with the functional transport assays except for PEPT transporters. Chronic hypoxia results in significant alterations in the mRNA expression and functional activity of solute transporters in ocular tissues.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23607566      PMCID: PMC3973437          DOI: 10.1021/mp3007133

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  65 in total

1.  Effect of hypoxic stress-activated Polo-like kinase 3 on corneal epithelial wound healing.

Authors:  Jiawei Lu; Ling Wang; Wei Dai; Luo Lu
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-26       Impact factor: 4.799

Review 2.  The role of blood-ocular barrier transporters in retinal drug disposition: an overview.

Authors:  Masatoshi Tomi; Ken-ichi Hosoya
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-09       Impact factor: 4.481

3.  Characteristics of glycine transport across the inner blood-retinal barrier.

Authors:  Masashi Okamoto; Shin-ichi Akanuma; Masanori Tachikawa; Ken-ichi Hosoya
Journal:  Neurochem Int       Date:  2009-08-08       Impact factor: 3.921

4.  Copper transport into the secretory pathway is regulated by oxygen in macrophages.

Authors:  Carine White; Taiho Kambe; Yan G Fulcher; Sherri W Sachdev; Ashley I Bush; Kevin Fritsche; Jaekwon Lee; Thomas P Quinn; Michael J Petris
Journal:  J Cell Sci       Date:  2009-04-07       Impact factor: 5.285

5.  Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy.

Authors:  Bernard Burke; Athina Giannoudis; Kevin P Corke; Dalvir Gill; Michael Wells; Loems Ziegler-Heitbrock; Claire E Lewis
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

6.  Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerve.

Authors:  Rajendra S Kadam; Uday B Kompella
Journal:  J Pharmacol Exp Ther       Date:  2009-11-19       Impact factor: 4.030

7.  Distribution of rat organic anion transporting polypeptide-E (oatp-E) in the rat eye.

Authors:  Aki Ito; Katsuhiro Yamaguchi; Hiroshi Tomita; Takehiro Suzuki; Tohru Onogawa; Takeaki Sato; Hiroya Mizutamari; Tsuyoshi Mikkaichi; Toshiyuki Nishio; Takashi Suzuki; Michiaki Unno; Hironobu Sasano; Takaaki Abe; Makoto Tamai
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

8.  Transcorneal permeation of L- and D-aspartate ester prodrugs of acyclovir: delineation of passive diffusion versus transporter involvement.

Authors:  Soumyajit Majumdar; Tushar Hingorani; Ramesh Srirangam; Rama Sarma Gadepalli; John M Rimoldi; Michael A Repka
Journal:  Pharm Res       Date:  2008-10-07       Impact factor: 4.200

9.  Reduced l-arginine transport and nitric oxide synthesis in human umbilical vein endothelial cells from intrauterine growth restriction pregnancies is not further altered by hypoxia.

Authors:  P Casanello; B Krause; E Torres; V Gallardo; M González; C Prieto; C Escudero; M Farías; L Sobrevia
Journal:  Placenta       Date:  2009-06-07       Impact factor: 3.481

10.  Validation of suitable house keeping genes for hypoxia-cultured human chondrocytes.

Authors:  Casper Bindzus Foldager; Samir Munir; Michael Ulrik-Vinther; Kjeld Søballe; Cody Bünger; Martin Lind
Journal:  BMC Mol Biol       Date:  2009-10-09       Impact factor: 2.946

View more
  3 in total

Review 1.  Drug transporters in the central nervous system.

Authors:  Bruno Stieger; Bo Gao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

2.  Imidazole-based alkaloid derivative LCB54-0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization.

Authors:  Byung-Hak Kim; Junyeop Lee; Jun-Sub Choi; Dae Young Park; Ho Young Song; Tae Kyo Park; Chung-Hyun Cho; Sang-Kyu Ye; Choun-Ki Joo; Gou Young Koh; Tae-Yoon Kim
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

3.  Development of a Bioinformatics Framework for Identification and Validation of Genomic Biomarkers and Key Immunopathology Processes and Controllers in Infectious and Non-infectious Severe Inflammatory Response Syndrome.

Authors:  Dong Ling Tong; Karen E Kempsell; Tamas Szakmany; Graham Ball
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.